نتائج البحث - Paul C. Shellito

  • يعرض 1 - 14 نتائج من 14
تنقيح النتائج
  1. 1
    Techniques and Complications

    Techniques and Complications حسب Paul C. Shellito, Ronald A. Malt

    منشور في 1985
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Percutaneous Endoscopic Gastrostomy in Head and Neck Cancer Patients

    Percutaneous Endoscopic Gastrostomy in Head and Neck Cancer Patients حسب John G. Hunter, LINDA LAURETANO, Paul C. Shellito

    منشور في 1989
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Selection factors for local excision or abdominoperineal resection of early stage rectal cancer

    Selection factors for local excision or abdominoperineal resection of early stage rectal cancer حسب Christopher G. Willett, Carolyn C. Compton, Paul C. Shellito, J.T. Efird

    منشور في 1994
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Wound Dehiscence After Abdominoperineal Resection for Low Rectal Cancer Is Associated With Decreased Survival

    Wound Dehiscence After Abdominoperineal Resection for Low Rectal Cancer Is Associated With Decreased Survival حسب Alexander T. Hawkins, David L. Berger, Paul C. Shellito, Patrica Sylla, Liliana Bordeianou

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    The Impact of 5-Fluorouracil and Intraoperative Electron Beam Radiation Therapy on the Outcome of Patients With Locally Advanced Primary Rectal and Rectosigmoid Cancer

    The Impact of 5-Fluorouracil and Intraoperative Electron Beam Radiation Therapy on the Outcome of Patients With Locally Advanced Primary Rectal and Rectosigmoid Cancer حسب Bruce M. Nakfoor, Christopher G. Willett, Paul C. Shellito, Donald S. Kaufman, William J. Daly

    منشور في 1998
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma

    Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma حسب Christopher G. Willett, Paul C. Shellito, Joel E. Tepper, Roseann Eliseo, Karen Convery, William C. Wood

    منشور في 1991
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Long-Term Follow-Up of Patients With Rectal Cancer Managed by Local Excision With and Without Adjuvant Irradiation

    Long-Term Follow-Up of Patients With Rectal Cancer Managed by Local Excision With and Without Adjuvant Irradiation حسب Arnab Chakravarti, Carolyn C. Compton, Paul C. Shellito, William C. Wood, Jerome C. Landry, Shelley R. Machuta, David W. Kaufman, Marek Ancukiewicz, Christopher G. Willett

    منشور في 1999
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Early-Stage Rectal Cancer

    Early-Stage Rectal Cancer حسب Sagar A. Patel, Yu‐Hui Chen, Jason L. Hornick, Paul J. Catalano, Jonathan A. Nowak, Lawrence Zukerberg, Ronald Bleday, Paul C. Shellito, Theodore S. Hong, Harvey J. Mamon

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1α, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer

    Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1α, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer حسب Lei Xu, Dan G. Duda, Emmanuelle di Tomaso, Marek Ancukiewicz, Daniel C. Chung, Gregory Y. Lauwers, Rekha Samuel, Paul C. Shellito, Brian G. Czito, Pei‐Chun Lin, Martin Poleski, Rex C. Bentley, Jeffrey W. Clark, Christopher G. Willett, Rakesh K. Jain

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Plasma Soluble VEGFR-1 Is a Potential Dual Biomarker of Response and Toxicity for Bevacizumab with Chemoradiation in Locally Advanced Rectal Cancer

    Plasma Soluble VEGFR-1 Is a Potential Dual Biomarker of Response and Toxicity for Bevacizumab with Chemoradiation in Locally Advanced Rectal Cancer حسب Dan G. Duda, Christopher G. Willett, Marek Ancukiewicz, Emmanuelle di Tomaso, Mira Shah, Brian G. Czito, Rex C. Bentley, Martin Poleski, Gregory Y. Lauwers, Madeline Carroll, Douglas S. Tyler, Christopher R. Mantyh, Paul C. Shellito, Jeffrey W. Clark, Rakesh K. Jain

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    A Safety and Survival Analysis of Neoadjuvant Bevacizumab with Standard Chemoradiation in a Phase I/II Study Compared with Standard Chemoradiation in Locally Advanced Rectal Cancer

    A Safety and Survival Analysis of Neoadjuvant Bevacizumab with Standard Chemoradiation in a Phase I/II Study Compared with Standard Chemoradiation in Locally Advanced Rectal Cancer حسب Christopher G. Willett, Dan G. Duda, Marek Ancukiewicz, Mira Shah, Brian G. Czito, Rex C. Bentley, Martin Poleski, Hiroshi Fujita, Gregory Y. Lauwers, Madeline Carroll, Douglas S. Tyler, Christopher R. Mantyh, Paul C. Shellito, Daniel C. Chung, Jeffrey W. Clark, Rakesh K. Jain

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study

    Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study حسب Christopher G. Willett, Dan G. Duda, Emmanuelle di Tomaso, Yves Boucher, Marek Ancukiewicz, Dushyant V. Sahani, Johanna Lahdenranta, Daniel C. Chung, Alan J. Fischman, Gregory Y. Lauwers, Paul C. Shellito, Brian G. Czito, Terence Z. Wong, Erik K. Paulson, Martin Poleski, Željko Vujašković, Rex C. Bentley, Helen X. Chen, Jeffrey W. Clark, Rakesh K. Jain

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

    Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer حسب Christopher G. Willett, Yves Boucher, Emmanuelle di Tomaso, Dan G. Duda, Lance L. Munn, Ricky T. Tong, Daniel C. Chung, Dushyant V. Sahani, Sanjeeva P. Kalva, Sergey V. Kozin, Mari Mino, Kenneth S. Cohen, David T. Scadden, Alan C. Hartford, Alan J. Fischman, Jeffrey W. Clark, David P. Ryan, Andrew X. Zhu, Lawrence S. Blaszkowsky, Helen X Chen, Paul C. Shellito, Gregory Y. Lauwers, Rakesh K. Jain

    منشور في 2004
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Surrogate Markers for Antiangiogenic Therapy and Dose-Limiting Toxicities for Bevacizumab With Radiation and Chemotherapy: Continued Experience of a Phase I Trial in Rectal Cancer Patients

    Surrogate Markers for Antiangiogenic Therapy and Dose-Limiting Toxicities for Bevacizumab With Radiation and Chemotherapy: Continued Experience of a Phase I Trial in Rectal Cancer... حسب Christopher G. Willett, Yves Boucher, Dan G. Duda, Emmanuelle di Tomaso, Lance L. Munn, Ricky T. Tong, Sergey V. Kozin, Lucine Petit, Rakesh K. Jain, Daniel C. Chung, Dushyant V. Sahani, Sanjeeva P. Kalva, Kenneth S. Cohen, David T. Scadden, Alan J. Fischman, Jeffrey W. Clark, David P. Ryan, Andrew X. Zhu, Lawrence S. Blaszkowsky, Paul C. Shellito, Mari Mino‐Kenudson, Gregory Y. Lauwers

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: